Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US

IMPORTANCE: Understanding the severity of postvaccination SARS-CoV-2 (ie, COVID-19) breakthrough illness among people with HIV (PWH) can inform vaccine guidelines and risk-reduction recommendations. OBJECTIVE: To estimate the rate and risk of severe breakthrough illness among vaccinated PWH and peop...

Descripción completa

Detalles Bibliográficos
Autores principales: Lang, Raynell, Humes, Elizabeth, Coburn, Sally B., Horberg, Michael A., Fathi, Lily F., Watson, Eric, Jefferson, Celeena R., Park, Lesley S., Gordon, Kirsha S., Akgün, Kathleen M., Justice, Amy C., Napravnik, Sonia, Edwards, Jessie K., Browne, Lindsay E., Agil, Deana M., Silverberg, Michael J., Skarbinski, Jacek, Leyden, Wendy A., Stewart, Cameron, Hogan, Brenna C., Gebo, Kelly A., Marconi, Vincent C., Williams, Carolyn F., Althoff, Keri N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561947/
https://www.ncbi.nlm.nih.gov/pubmed/36227594
http://dx.doi.org/10.1001/jamanetworkopen.2022.36397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561947/
https://www.ncbi.nlm.nih.gov/pubmed/36227594
http://dx.doi.org/10.1001/jamanetworkopen.2022.36397

Ejemplares similares